Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer’s Disease: A Narrative Review

[44] Glutathione peroxidase

Wendel, A. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,011 · see citing works

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911 · see citing works

Glutathione peroxidases

Brigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904 · see citing works

Selenium in human health and disease

Fairweather-Tait, S. J., Bao, Y., Broadley, M. R., Collings, R., Ford, D., Hesketh, J. E., & Hurst, R. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3275 · Cited by 1,330 · see citing works

Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities

Lubos, E., Loscalzo, J., & Handy, D. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3586 · Cited by 1,280 · see citing works

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202 · see citing works

Serum amyloid A, the major vertebrate acute‐phase reactant

Uhlar, C., & Whitehead, A. S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00657.x · Cited by 1,101 · see citing works

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

de la Torre, J. C. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00683-0 · Cited by 834 · see citing works

Dysfunctional HDL and atherosclerotic cardiovascular disease

Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822 · see citing works

Evacetrapib and cardiovascular outcomes in high-risk vascular disease

Lincoff, A. M., Nicholls, S. J., Riesmeyer, J. S., Barter, P. J., Brewer, H. B., Fox, K. A. A., Gibson, C. M., Granger, C., Menon, V., Montalescot, G., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609581 · Cited by 801 · see citing works

High-Density Lipoprotein Subfractions - What the Clinicians Need to Know

Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 749 · see citing works

Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities

Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R. K., & Du, B. N. L. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400511-jlr200 · Cited by 716 · see citing works

Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

‡ (2010) · The Lancet · doi:10.1016/s0140-6736(10)60319-4 · Cited by 595 · see citing works

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease

Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U., & Mecocci, P. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00031-9 · Cited by 562 · see citing works

Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More

Costa, L. G., Garrick, J. M., Roqué, P. J., & Pellacani, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2986796 · Cited by 550 · see citing works

Serum amyloid A – a review

Sack, G. H. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0047-0 · Cited by 507 · see citing works

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

Camont, L., Chapman, M. J., & Kontush, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.013 · Cited by 471 · see citing works

Myeloperoxidase – A bridge linking inflammation and oxidative stress with cardiovascular disease

Ndrepepa, G. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.022 · Cited by 452 · see citing works

HDL and Reverse Cholesterol Transport: Basic Mechanisms and their Roles in Vascular Health and Disease

Ouimet, M., Barrett, T. J., & Fisher, E. (2019) · Circulation Research · doi:10.1161/circresaha.119.312617 · Cited by 416 · see citing works

Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species

Carr, A. C., McCall, M. R., & Frei, B. B. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1716 · Cited by 392 · see citing works

Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378 · see citing works

The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase.

Björnstedt, M., Xue, J., Huang, W., Åkesson, B., & Holmgren, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43889-6 · Cited by 364 · see citing works

Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis

Anstey, K. J., Ashby-Mitchell, K., & Peters, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160826 · Cited by 360 · see citing works

Oxidative stress in autoimmune rheumatic diseases

Smallwood, M. J., Nissim, A., Knight, A. R., Whiteman, M., Haigh, R. C., & Winyard, P. G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.086 · Cited by 347 · see citing works

Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation

Draganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & Du, B. N. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004543200 · Cited by 338 · see citing works

Neuronal expression of myeloperoxidase is increased in Alzheimer's disease

Green, P. S., Mendez, A. J., Jacob, J. S., Crowley, J. R., Growdon, W., Hyman, B. T., & Heinecke, J. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02527.x · Cited by 332 · see citing works

Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase

Breckwoldt, M. O., Chen, J. W., Stangenberg, L., Aikawa, E. R., Rodrı́guez, E., Qiu, S., Moskowitz, M. A., & Weissleder, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803945105 · Cited by 324 · see citing works

Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology

Ballatori, N., Krance, S. M., Marchan, R., & Hammond, C. L. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.004 · Cited by 318 · see citing works

Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease

Zaplatić, E., Bule, M. H., Shah, S. Z. A., Uddin, M. S., & Niaz, K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.055 · Cited by 298 · see citing works

Blood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults

Bowman, G. L., Dayon, L., Kirkland, R. E., Wojcik, J., Peyratout, G., Severin, I. C., Henry, H., Oikonomidi, A., Migliavacca, E., Bacher, M., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2857 · Cited by 295 · see citing works

Structure of HDL: Particle Subclasses and Molecular Components

Kontush, A., Lindahl, M. G., Lhomme, M., Calabresi, L., Chapman, M. J., & Davidson, W. S. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_1 · Cited by 284 · see citing works

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67478 · Cited by 269 · cited 2× · see citing works

Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review

Zhang, Y., Roh, Y. J., Han, S.-J., Park, I., Lee, H. M., Ok, Y. S., Lee, B. C., & Lee, S.-R. (2020) · Antioxidants · doi:10.3390/antiox9050383 · Cited by 267 · see citing works

Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit

Brites, F. D., Martín, M., Guillas, I., & Kontush, A. (2017) · BBA Clinical · doi:10.1016/j.bbacli.2017.07.002 · Cited by 265 · see citing works

HDL and cholesterol handling in the brain

Vitali, C., Wellington, C. L., & Calabresi, L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu148 · Cited by 254 · see citing works

Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages

Artl, A., Marsche, G., Lestavel, S., Sattler, W., & Malle, E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.763 · Cited by 254 · see citing works

Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles

Qi, Y., Guo, L., Jiang, Y., Shi, Y., Sui, H., & Zhao, L. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1762262 · Cited by 239 · see citing works

Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer's Disease

Torres, L. H., Quaglio, N. B., de Souza, G. T., Garcia, R. C. T., Dati, L. M. M., Moreira, W. L., Loureiro, A. P. D. M., Souza‐Talarico, J. N., Smid, J., Porto, C. S., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110284 · Cited by 235 · see citing works

Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer’s disease

Vural, H., Demirin, H., Kara, Y. B., Eren, İ., & Delibaş, N. (2010) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.02.002 · Cited by 235 · see citing works

Novel Biological Functions of High-Density Lipoprotein Cholesterol

Mineo, C., & Shaul, P. W. (2012) · Circulation Research · doi:10.1161/circresaha.111.258673 · Cited by 228 · see citing works

Extracellular Glutathione Peroxidase GPx3 and Its Role in Cancer

Chang, C. A., Worley, B. L., Phaëton, R., & Hempel, N. (2020) · Cancers · doi:10.3390/cancers12082197 · Cited by 226 · see citing works

Plasma Amyloid-β as a Predictor of Dementia and Cognitive Decline

Koyama, A. K., Okereke, O. I., Yang, T., Blacker, D., Selkoe, D. J., & Grodstein, F. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1841 · Cited by 220 · see citing works

Paraoxonases-1, -2 and -3: What are their functions?

Furlong, C. E., Marsillach, J., Jarvik, G. P., & Costa, L. G. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.036 · Cited by 208 · see citing works

Lipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer Dementias

Casado, Á., López-Fernández, M. E., Casado, M. C., & de la Torre, R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9453-3 · Cited by 207 · see citing works

Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease

van Himbergen, T. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.670 · Cited by 198 · see citing works

Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues

Marsillach, J., Mackness, B., Mackness, M., Riu, F., Beltrán‐Debón, R., Joven, J., & Camps, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.023 · Cited by 196 · see citing works

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on

Costa, L. G., Giordano, G., & Furlong, C. E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.008 · Cited by 188 · see citing works

Serum amyloid A impairs the antiinflammatory properties of HDL

Han, C. Y., Tang, C., Guevara, M. E., Hao, W., Wietecha, T., Shao, B., Subramanian, S., Omer, M., Wang, S., O’Brien, K. D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83475 · Cited by 171 · see citing works

Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N -(3-Oxododecanoyl)- l -Homoserine Lactone

Teiber, J. F., Horke, S., Haines, D. C., Chowdhary, P. K., Xiao, J., Kramer, G. L., Haley, R. W., & Draganov, D. I. (2008) · Infection and Immunity · doi:10.1128/iai.01606-07 · Cited by 160 · see citing works

Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

Tellis, C. C., & Tselepis, A. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.015 · Cited by 158 · see citing works

Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis

Guo, J.-T., Yu, J., Grass, D., de Beer, F. C., & Kindy, M. S. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05900.2002 · Cited by 153 · see citing works

The Roles of Biomarkers of Oxidative Stress and Antioxidant in Alzheimer’s Disease: A Systematic Review

Chang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 143 · see citing works

Diabetes and Hypercholesterolemia Increase Blood-Brain Barrier Permeability and Brain Amyloid Deposition: Beneficial Effects of the LpPLA2 Inhibitor Darapladib

Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M. C., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122254 · Cited by 140 · see citing works

Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia

Puertas, M. C., Martı́nez-Martos, J. M., Cobo, M., Carrera-González, M. P., Mayas, M. D., & Ramı́rez-Expósito, M. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.05.019 · Cited by 140 · see citing works

Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery

Cervellati, C., Trentini, A., Pecorelli, A., & Valacchi, G. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8076 · Cited by 137 · see citing works

Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type—Place of the extracellular glutathione peroxidase

Ceballos-Picot, I., Merad-Boudia, M., Nicole, A., Thévenin, M., Hellier, G., Legrain, S., & Berr, C. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02058-6 · Cited by 130 · see citing works

SR-BI Mediated Transcytosis of HDL in Brain Microvascular Endothelial Cells Is Independent of Caveolin, Clathrin, and PDZK1

Fung, K. Y., Wang, C., Nyegaard, S., Heit, B., Fairn, G. D., & Lee, W. L. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00841 · Cited by 129 · see citing works

HDL from an Alzheimer's disease perspective

Button, E. B., Robert, J., Caffrey, T. M., Fan, J., Zhao, W., & Wellington, C. L. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000604 · Cited by 114 · see citing works

Lysophosphatidylcholine increases endothelial permeability: role of PKCα and RhoA cross talk

Huang, F., Subbaiah, P. V., Holian, O., Zhang, J., Johnson, A., Gertzberg, N., & Lum, H. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00003.2005 · Cited by 113 · see citing works

Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke

Yu, G., Liang, Y. S., Huang, Z., Jones, D. W., Pritchard, K. A., & Zhang, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0583-x · Cited by 103 · see citing works

Polymorphisms in the PON gene cluster are associated with Alzheimer disease

Erlich, P. M., Lunetta, K. L., Cupples, L. A., Huyck, M., Green, R. C., Baldwin, C. T., & Farrer, L. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi428 · Cited by 99 · see citing works

Selenium-Enriched Foods Are More Effective at Increasing Glutathione Peroxidase (GPx) Activity Compared with Selenomethionine: A Meta-Analysis

Bermingham, E. N., Hesketh, J. E., Sinclair, B. R., Koolaard, J. P., & Roy, N. C. (2014) · Nutrients · doi:10.3390/nu6104002 · Cited by 99 · see citing works

Myeloperoxidase-Derived Oxidants Induce Blood-Brain Barrier Dysfunction In Vitro and In Vivo

Üllen, A., Singewald, E., Kónya, V., Fauler, G., Reicher, H., Nusshold, C., Hammer, A., Kratky, D., Heinemann, Á., Holzer, P. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064034 · Cited by 96 · see citing works

Paraoxonase 1 and HDL maturation

Gugliucci, A., & Menini, T. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.09.016 · Cited by 95 · see citing works

Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer's Disease Models: the Control of Neuroinflammation

Paterniti, I., Cordaro, M., Campolo, M., Siracusa, R., Cornelius, C., Navarra, M., Cuzzocrea, S., & Esposito, E. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140806124322 · Cited by 90 · cited 1× · see citing works

PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death

Schweikert, E.-M., Devarajan, A., Witte, I., Wilgenbus, P., Amort, J., Förstermann, U., Shabazian, A., Grijalva, V. R., Shih, D. M., Farias‐Eisner, R., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.35 · Cited by 89 · see citing works

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation

Pastori, D., Pignatelli, P., Farcomeni, A., Menichelli, D., Nocella, C., Carnevale, R., & Violi, F. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003682 · Cited by 83 · see citing works

High-density lipoprotein inhibits serum amyloid A–mediated reactive oxygen species generation and NLRP3 inflammasome activation

Shridas, P., de Beer, M. C., & Webb, N. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002428 · Cited by 82 · see citing works

Role of serum amyloid A in atherosclerosis

Shridas, P., & Tannock, L. R. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000616 · Cited by 81 · see citing works

Serum amyloid A primes microglia for ATP-dependent interleukin-1β release

Facci, L., Barbierato, M., Zusso, M., Skaper, S. D., & Giusti, P. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1205-6 · Cited by 79 · see citing works

Serum Amyloid A Is an Exchangeable Apolipoprotein

Wilson, P. G., Thompson, J. C., Shridas, P., McNamara, P. J., de Beer, M. C., de Beer, F. C., Webb, N. R., & Tannock, L. R. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310979 · Cited by 76 · see citing works

Increased Myeloperoxidase Plasma Levels in Patients with Alzheimer's Disease

Tzikas, S., Schlak, D., Sopova, K., Gatsiou, A., Stakos, D., Stamatelopoulos, K. S., Stellos, K., & Laske, C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131469 · Cited by 75 · see citing works

Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk

Soria-Florido, M. T., Castañer, O., Lassale, C. M., Estruch, R., Salas‐Salvadó, J., Martínez‐González, M. Á., Corella, D., Ros, E., Arós, F., Elosúa, R., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041658 · Cited by 75 · see citing works

ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease

Marchi, C., Adorni, M. P., Caffarra, P., Ronda, N., Spallazzi, M., Barocco, F., Galimberti, D., Bernini, F., & Zimetti, F. (2019) · Journal of Lipid Research · doi:10.1194/jlr.p091033 · Cited by 74 · see citing works

Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II

Robertson, K. S., Hawe, E., Miller, G. J., Talmud, P. J., & Humphries, S. E. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.09.008 · Cited by 72 · see citing works

Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1

Melchior, J., Street, S. E., Andraski, A. B., Furtado, J. D., Sacks, F. M., Shute, R. L., Greve, E. I., Swertfeger, D. K., Li, H., SHAH, A. S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075382 · Cited by 72 · see citing works

Myeloperoxidase Deficiency Inhibits Cognitive Decline in the 5XFAD Mouse Model of Alzheimer’s Disease

Volkman, R., Ben‐Zur, T., Kahana, A., Garty, B. Z., & Offen, D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00990 · Cited by 72 · see citing works

Systemic Oxidative Stress Associated with the Neurological Diseases of Aging

Serra, J. A., Domínguez, R. O., Marschoff, E. R., Guareschi, E. M., Famulari, A. L., & BOVERIS, A. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9997-5 · Cited by 70 · see citing works

Phospholipase Action of Platelet-activating Factor Acetylhydrolase, but Not Paraoxonase-1, on Long Fatty Acyl Chain Phospholipid Hydroperoxides

Kriska, T., Marathe, G. K., Schmidt, J. C., McIntyre, T. M., & Girotti, A. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608135200 · Cited by 70 · see citing works

Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum

Rothem, L., Hartman, C., Dahan, A., Lachter, J., Eliakim, R., & Shamir, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.003 · Cited by 69 · see citing works

The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women

Manus, J. M., McEneny, J., Thompson, W., & Young, I. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00154-8 · Cited by 67 · see citing works

Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells

Lum, H., Qiao, J., Walter, R. J., Huang, F., Subbaiah, P. V., Kim, K. S., & Holian, O. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00359.2003 · Cited by 64 · see citing works

Paraoxonase-3 Is Depleted from the High-Density Lipoproteins of Autoimmune Disease Patients with Subclinical Atherosclerosis

Marsillach, J., Becker, J. O., Vaisar, T., Hahn, B. H., Brunzell, J. D., Furlong, C. E., de Boer, I. H., McMahon, M. A., Hoofnagle, A. N., & DCCT/EDIC Research Group (2015) · Journal of Proteome Research · doi:10.1021/pr5011586 · Cited by 61 · see citing works

Adenovirus-Mediated Expression of Human Paraoxonase 3 Protects Against the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice

Ng, C. J., Bourquard, N., Hama, S. Y., Shih, D. M., Grijalva, V. R., Navab, M., Fogelman, A. M., & Reddy, S. T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.134189 · Cited by 60 · see citing works

Association between Alzheimer's Disease and a Functional Polymorphism in the Myeloperoxidase Gene

Crawford, F., Freeman, M. J., Schinka, J. A., Morris, M. D., Abdullah, L. I., Richards, D., Sevush, S., Duara, R., & MULLAN, M. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7560 · Cited by 59 · see citing works

A Role for the High-Density Lipoprotein Receptor SR-B1 in Synovial Inflammation via Serum Amyloid-A

Mullan, R. H., McCormick, J., Connolly, M. C., Bresnihan, B., Veale, D. J., & Fearon, U. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090014 · Cited by 57 · see citing works

HDL Proteome and Alzheimer’s Disease: Evidence of a Link

Marsillach, J., Adorni, M. P., Zimetti, F., Papotti, B., Zuliani, G., & Cervellati, C. (2020) · Antioxidants · doi:10.3390/antiox9121224 · Cited by 57 · see citing works

Lipoprotein-associated phospholipase A2 in coronary heart disease: Review and meta-analysis

Li, D., Zhao, L., Yu, J., Zhang, W., Du, R., Liu, X., Liu, Y., Chen, Y., Zeng, R., Cao, Y., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.12.006 · Cited by 56 · see citing works

A 24‐week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease

Maher‐Edwards, G., De'Ath, J., Barnett, C., Lavrov, A., & Lockhart, A. (2015) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2015.06.003 · Cited by 55 · see citing works

Low Serum Glutathione Peroxidase Activity Is Associated with Increased Cardiovascular Mortality in Individuals with Low HDLc’s

Buijsse, B., Lee, D., Steffen, L. M., Erickson, R. R., Luepker, R. V., Jacobs, D. R., & Holtzman, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038901 · Cited by 55 · see citing works

Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study

Marksteiner, J., Imarhiagbe, D., Defrancesco, M., Deisenhammer, E., Kemmler, G., & Humpel, C. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.001 · Cited by 54 · see citing works

Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?

Shao, B., & Heinecke, J. W. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1402680 · Cited by 53 · see citing works

Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid

Wu, C., Bawa, K. K., Ouk, M., Leung, N., Yu, D., Lanctôt, K. L., Herrmann, N., Pakosh, M. T., & Swardfager, W. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101130 · Cited by 52 · see citing works

Increased Risk for Alzheimer Disease With the Interaction of MPO and A2M Polymorphisms

Zappia, M., Manna, I., Serra, P., Cittadella, R., Andreoli, V., Russa, A. L., Annesi, F., Spadafora, P., Romeo, N., Nicoletti, G., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.341 · Cited by 51 · see citing works

Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke

Shang, J., Yamashita, T., Fukui, Y., Song, D., Li, X., Zhai, Y., Nakano, Y., Morihara, R., Hishikawa, N., Ohta, Y., et al. (2018) · Journal of Clinical Neurology · doi:10.3988/jcn.2018.14.1.29 · Cited by 49 · see citing works

Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients.

Fernandes, M. A. S., Proenca, M. T., Nogueira, A. J. A., Grazina, M. M., Oliveira, L. M. V., Fernandes, A. I., Santiago, B., Santana, I. J., & Oliveira, C. R. (1999) · International Journal of Molecular Medicine · doi:10.3892/ijmm.4.2.179 · Cited by 48 · see citing works

La Lp-PLA2, marqueur d’inflammation vasculaire et de vulnérabilité de la plaque d’athérosclérose

Bonnefont‐Rousselot, D. (2015) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2015.09.002 · Cited by 48 · see citing works

Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction

Zimetti, F., VUONO, S. D., Gomaraschi, M., Adorni, M. P., Favari, E., Ronda, N., Ricci, M. A., Veglia, F., Calabresi, L., & Lupattelli, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.p076463 · Cited by 47 · see citing works

Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer’s Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1

Bacchetti, T., Vignini, A., Giulietti, A., Nanetti, L., Provinciali, L., Luzzi, S., Mazzanti, L., & Ferretti, G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143096 · Cited by 46 · see citing works

Serum amyloid A (SAA)-induced remodeling of CSF-HDL

Miida, T., Yamada, T., Seino, U., Ito, M., Fueki, Y., Takahashi, A., Kosuge, K., Soda, S., Hanyu, O., Obayashi, K., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.013 · Cited by 46 · see citing works

Lipoprotein Phospholipase A2 and Cerebral Microbleeds in the Framingham Heart Study

Romero, J. R., Preis, S. R., Beiser, A., DeCarli, C. S., Lee, D. Y., Viswanathan, A., Benjamin, E. J., Fontes, J. D., Au, R., Pikula, A., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.656744 · Cited by 45 · see citing works

Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention

Ossoli, A., Pavanello, C., Giorgio, E., Calabresi, L., & Gomaraschi, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180316115726 · Cited by 45 · see citing works

Apolipoprotein Serum Amyloid A in Alzheimer's Disease

Kindy, M., Yu, J., Guo, J.-T., & Zhu, H. (1999) · Journal of Alzheimer's Disease · doi:10.3233/jad-1999-1303 · Cited by 44 · see citing works

PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis

Shih, D. M., Yu, J. M., Vergnes, L., Dali‐Youcef, N., Champion, M. D., Devarajan, A., Zhang, P., Castellani, L. W., Brindley, D. N., Jamey, C., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-260570 · Cited by 44 · see citing works

Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study

Fitzpatrick, A. L., Irizarry, M. C., Cushman, M., Jenny, N. S., Chi, G. C., & Koro, C. E. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.04.032 · Cited by 41 · see citing works

Lipoprotein‐associated phospholipase A2 is associated with risk of dementia

van Oijen, M., van der Meer, I. M., Albert Hofman, D., Witteman, J. C. M., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20721 · Cited by 40 · see citing works

Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development

Cervellati, C., Valacchi, G., Tisato, V., Zuliani, G., & Marsillach, J. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05875-5 · Cited by 40 · see citing works

Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A

Barbierato, M., Borri, M., Facci, L., Zusso, M., Skaper, S., & Giusti, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12529-7 · Cited by 37 · see citing works

Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese

Cheng, Z., Yin, J., Yuan, H., Jin, C., Zhang, F., Wang, Z., Liu, X., Wu, Y., Wang, T., & Xiao, S. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00414 · Cited by 37 · see citing works

Serum Amyloid A Receptor Blockade and Incorporation into High-Density Lipoprotein Modulates Its Pro-Inflammatory and Pro-Thrombotic Activities on Vascular Endothelial Cells

Chami, B., Barrie, N., Cai, X., Wang, X., Paul-Heng, M., Morton-Chandra, R., Sharland, A. F., Dennis, J. M., Freedman, S., & Witting, P. K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511101 · Cited by 36 · see citing works

Identification of paraoxonase 3 gene (PON3) missense mutations in a population of southern Italy

Campo, S., Sardo, M. A., Campo, G. M., Avenoso, A., Castaldo, M., D’Ascola, A., Giunta, E., Calatroni, A., & Saitta, A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.11.007 · Cited by 36 · see citing works

Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage

Cervellati, C., Vigna, G. B., Trentini, A., Sanz, J. M., Zimetti, F., Nora, E. D., Morieri, M. L., Zuliani, G., & Passaro, A. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.218 · Cited by 36 · see citing works

Serum amyloid A1 is involved in amyloid plaque aggregation and memory decline in amyloid beta abundant condition

Jang, S., Jang, W. Y., Choi, M., Lee, J., Kwon, W., Yi, J., Park, S. J., Yoon, D., Lee, S., Kim, M. O., et al. (2019) · Transgenic Research · doi:10.1007/s11248-019-00166-x · Cited by 35 · see citing works

Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study

Leininger‐Muller, B., Hoy, A., Herbeth, B., Pfister, M., Sérot, J., Stavljenic-Rukavina, M., Massana, L., Passmore, P., Siest, G., & Visvikis‐Siest, S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00795-x · Cited by 34 · see citing works

Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study

Davidson, J. E., Lockhart, A., Amos, L., Stirnadel-Farrant, H. A., Mooser, V., Sollberger, M. A., Regeniter, A., Monsch, A. U., & Irizarry, M. C. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt154 · Cited by 34 · see citing works

TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease

Carlson, C. S., Heagerty, P. J., Hatsukami, T. S., Richter, R. J., Ranchalis, J., Lewis, J., Bacus, T. J., McKinstry, L. A., Schellenberg, G. D., Rieder, M. J., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500517-jlr200 · Cited by 34 · see citing works

Lipoprotein‐associated phospholipase A2, homocysteine, and Alzheimer's disease

Doody, R. S., Demirovic, J., Ballantyne, C. M., Chan, W., Barber, R. C., Powell, S. Z.-E., & Pavlik, V. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.08.001 · Cited by 34 · see citing works

Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve

Gursky, O. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00888-y · Cited by 33 · see citing works

Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia

Vigna, G. B., Satta, E., Bernini, F., Boarini, S., Bosi, C., Giusto, L., Pinotti, E., Tarugi, P., Vanini, A., Volpato, S., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.02.010 · Cited by 30 · see citing works

Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer’s Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1

(2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-159901 · Cited by 29 · see citing works

Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery disease

Rull, A., García, R., Fernández-Sénder, L., García‐Heredia, A., Aragonès, G., Beltrán‐Debón, R., Marsillach, J., Alegret, J. M., Martín-Paredero, V., Mackness, B., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.021 · Cited by 28 · see citing works

Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes

Cai, R., Huang, R., Han, J., Sun, H., Sun, J. L., Xia, W., Tian, S., Dong, X., Shen, Y., & Wang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12515-z · Cited by 27 · see citing works

Cardioprotective Properties of HDL: Structural and Functional Considerations

Pappa, E. T., Elisaf, M., Kostara, C. E., Bairaktari, E. T., & Tsimihodimos, V. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190201142321 · Cited by 27 · see citing works

High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice

Cai, X., Ahmad, G., Hossain, F., Liu, Y., Wang, X., Dennis, J. M., Freedman, B., & Witting, P. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041316 · Cited by 26 · see citing works

Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation

Aragonès, G., García‐Heredia, A., Guardiola, M., Rull, A., Beltrán‐Debón, R., Marsillach, J., Alonso‐Villaverde, C., Mackness, B., Mackness, M., Pedro‐Botet, J., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.p018457 · Cited by 23 · see citing works

Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report

Sans, T., Rull, A., Luna, J. D., Mackness, B., Mackness, M., Joven, J., Ibañez, M., Pariente, R., Rodriguez, M., Ortı́n, X., et al. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0896 · Cited by 22 · see citing works

Myeloperoxidase: The Good, the Bad, and the Ugly

Lefkowitz, D. L., Mone, J., & Lefkowitz, S. S. (2010) · Current Immunology Reviews · doi:10.2174/157339510791111691 · Cited by 22 · see citing works

Lactonase Activity and Lipoprotein‐Phospholipase A2 as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study

Hayek, J., Cervellati, C., Crivellari, I., Pecorelli, A., & Valacchi, G. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5694058 · Cited by 22 · see citing works

Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease

Trentini, A., Rosta, V., Spadaro, S., Bellini, T., Rizzo, P., Sega, F. V. D., Passaro, A., Zuliani, G., Gentili, V., Campo, G. C., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0817 · Cited by 22 · see citing works

Distribution of Paraoxonase‐1 (PON‐1) and Lipoprotein Phospholipase A2 (Lp‐PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes

Passaro, A., Vigna, G. B., Romani, A., Sanz, J. M., Cavicchio, C., Bonaccorsi, G., Valacchi, G., & Cervellati, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1752940 · Cited by 21 · see citing works

Serum amyloid A-induced blood-brain barrier dysfunction associated with decreased claudin-5 expression in rat brain endothelial cells and its inhibition by high-density lipoprotein in vitro

Matsumoto, J., Dohgu, S., Takata, F., Iwao, T., Kimura, I., Tomohiro, M., Aono, K., Kataoka, Y., & Yamauchi, A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135352 · Cited by 21 · see citing works

Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver disease

García‐Heredia, A., Marsillach, J., Aragonès, G., Guardiola, M., Rull, A., Beltrán‐Debón, R., Folch, A., Mackness, B., Mackness, M., Pedro‐Botet, J., et al. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.08.003 · Cited by 19 · see citing works

Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades

D'Arrigo, J. S. (2020) · Biomimetics · doi:10.3390/biomimetics5010011 · Cited by 19 · see citing works

Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies

Zhou, J., Lu, Y., Wang, S., & Chen, K. (2020) · Inflammation Research · doi:10.1007/s00011-020-01325-1 · Cited by 18 · see citing works

The association of MPO gene promoter polymorphisms with Alzheimer’s disease risk in Chinese Han population

Ji, W., & Zhang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22330 · Cited by 17 · see citing works

Changes in Serum Amyloid A (SAA) and 8-OHdG in Patients with Senile Early Cognitive Impairment

Cao, X., & Chen, P. (2020) · Medical Science Monitor · doi:10.12659/msm.919586 · Cited by 16 · see citing works

Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome

Chang, C., Pan, Y., Du, H., Wang, X., & Li, X. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.08.005 · Cited by 14 · see citing works

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179 · see citing works

Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder

Wei, Y., Wang, T., Li, G., Feng, J., Deng, L., Xu, H., Yin, L., Ma, J., Chen, D., & Chen, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.941728 · Cited by 99 · see citing works

Punicic Acid and Its Role in the Prevention of Neurological Disorders: A Review

Guerra-Vázquez, C. M., Ávila, M. M., Guajardo‐Flores, D., & Antunes‐Ricardo, M. (2022) · Foods · doi:10.3390/foods11030252 · Cited by 55 · see citing works

Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis

Zuin, M., Cervellati, C., Trentini, A., Passaro, A., Rosta, V., Zimetti, F., & Zuliani, G. (2021) · Diagnostics · doi:10.3390/diagnostics11060984 · Cited by 45 · see citing works

Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders

Turri, M., Marchi, C., Adorni, M. P., Calabresi, L., & Zimetti, F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159123 · Cited by 54 · see citing works

Systemic inflammation and oxidative stress markers in patients with unipolar and bipolar depression: A large-scale study

Wei, Y., Gao, H., Luo, Y., Feng, J., Li, G., Wang, T., Xu, H., Yin, L., Ma, J., & Chen, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.156 · Cited by 40 · see citing works

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides

Sergi, D., Zauli, E., Tisato, V., Secchiero, P., Zauli, G., & Cervellati, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054403 · Cited by 32 · see citing works

Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases

Clementino, A., Marchi, C., Pozzoli, M., Bernini, F., Zimetti, F., & Sonvico, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716380 · Cited by 29 · see citing works

Paraoxonases at the Heart of Neurological Disorders

Khalaf, F. K., Connolly, J. A., Khatib-Shahidi, B. Z., Albehadili, A., Tassavvor, I., Ranabothu, M., Eid, N., Dube, P. R., Khouri, S. J., Malhotra, D. K., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086881 · Cited by 22 · see citing works

Long-Term Treatment of Cuban Policosanol Attenuates Abnormal Oxidative Stress and Inflammatory Response via Amyloid Plaques Reduction in 5xFAD Mice

Kim, J., Lim, D.-K., Suh, Y., & Chang, K. (2021) · Antioxidants · doi:10.3390/antiox10081321 · Cited by 21 · see citing works

Decoding Health: Exploring Essential Biomarkers Linked to Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus

Mukherjee, S., & Im, S. (2025) · Biomedicines · doi:10.3390/biomedicines13020359 · Cited by 19 · see citing works

A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease

Rani, A., & Marsche, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051504 · Cited by 19 · see citing works

Paraoxonase 1 activity in patients with Alzheimer disease: Systematic review and meta-analysis.

Zuin, M., Rosta, V., Trentini, A., Bosi, C., Zuliani, G., & Cervellati, C. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110601 · Cited by 16 · see citing works

Microencapsulated curcumin from Curcuma longa modulates diet-induced hypercholesterolemia in Sprague Dawley rats

Ashraf, H., Butt, M. S., Ul‐Haq, I., Nadeem, M., Aadil, R. M., Alexandru Vasile, R. U. S. U., & Trif, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1026890 · Cited by 15 · see citing works

l-Glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals

Pires, R. S., Braga, P. G. S., Santos, J. M. B., do Amaral, J. B., Amirato, G. R., Trettel, C. D. S., Santos, C. A. F., Vaisberg, M. W., Nali, L. H. D. S., Vieira, R. P., et al. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111584 · Cited by 14 · see citing works

Post‐GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3

Panyard, D. J., Reus, L. M., Ali, M., Liu, J., Deming, Y. K., Lu, Q., Kollmorgen, G., Carboni, M., Wild, N., Visser, P. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13848 · Cited by 14 · see citing works

Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders

Kwak, I. H., Kim, Y. E., Kim, Y. J., Noh, H., Lee, J., Yu, J. K., & Ma, H. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107155 · Cited by 14 · see citing works

Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable

Eiser, A. R., & Fülöp, T. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221078 · Cited by 14 · see citing works

Effect of Obesity and High-Density Lipoprotein Concentration on the Pathological Characteristics of Alzheimer’s Disease in High-Fat Diet-Fed Mice

Choi, M., Kim, D., Youn, Y.-J., Ryu, J., & Jeong, Y. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012296 · Cited by 13 · see citing works

Modulation of the Cellular microRNA Landscape: Contribution to the Protective Effects of High-Density Lipoproteins (HDL)

Graham, A. (2023) · Biology · doi:10.3390/biology12091232 · Cited by 14 · see citing works

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia

Zuliani, G., Marsillach, J., Trentini, A., Rosta, V., & Cervellati, C. (2023) · Antioxidants · doi:10.3390/antiox12030597 · Cited by 12 · see citing works

Inflammation Markers in Patients with Bipolar Disorder Who Have Committed Offenses and Their Relationship with Criminal Behavior

Emir, B. S., Yıldız, S., Kılıçaslan, A. K., Kurt, O., Uğur, K., Tabara, M. F., & Aydın, S. (2023) · Medicina · doi:10.3390/medicina59101725 · Cited by 12 · see citing works

Untitled work

Papotti (2024) · doi:10.1177/13872877241284213 · Cited by 11 · see citing works

Clinical and Diagnostic Value of High-Density Lipoprotein-Based Inflammatory Indices and Lipid Ratios in Young Adults with Schizophrenia

Chen, L., Zheng, C., Luan, H., & Chen, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s473528 · Cited by 10 · see citing works

Oxidized High-Density Lipoprotein Induces Endothelial Fibrosis Promoting Hyperpermeability, Hypotension, and Increased Mortality

Rojas, M., Prado, Y., Tapía, P., Carreño, L. J., Cabello‐Verrugio, C., & Simón, F. (2022) · Antioxidants · doi:10.3390/antiox11122469 · Cited by 10 · see citing works

Gender-specific differences in the association of HDL and HDL-related oxidative stress indicators with the occurrence of major depressive disorder and bipolar disorder: A large-scale study

Wei, Y., Zhang, C., Sun, B., Lin, J., Zhao, Y., Chen, Y., Gao, H., Li, J., Li, G., Feng, J., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119530 · Cited by 7 · see citing works

High-density Lipoprotein Over Midlife and Future Cognition in Women: The SWAN HDL Ancillary Study

Qi, M., Billheimer, J. T., Chang, C. H., Janssen, İ., Brooks, M. M., Orchard, T. J., Karlamangla, A. S., Barinas‐Mitchell, E., Derby, C. A., McConnell, D. S., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae697 · Cited by 6 · see citing works

GPx3 Promotes Functional Recovery after Spinal Cord Injury by Inhibiting Microglial Pyroptosis Through IRAK4/ROS/NLRP3 Axis

Liu, Z., Shi, J., Tu, K., Ma, H., Chen, J., Xiang, X., Zou, P., Liao, C., Ding, R., Huang, Z., et al. (2025) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0618 · Cited by 7 · see citing works

Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia

Romagnoli, T., Ortolani, B., Sanz, J. M., Trentini, A., Seripa, D., Nora, E. D., Capatti, E., Cervellati, C., Passaro, A., Zuliani, G., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117537 · Cited by 6 · see citing works

A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality

Cervellati, C., Trentini, A., Rosta, V., Zuliani, G., Sega, F. V. D., Fortini, F., Rizzo, P., Cimaglia, P., & Campo, G. C. (2023) · Current Vascular Pharmacology · doi:10.2174/1570161121666230221142131 · Cited by 5 · see citing works

Evaluation of the relationship among gene expressions and enzyme activities with antioxidant role and presenilin 1 expression in Alzheimer's disease

Işık, M., Tunç, A., Duran, H. E., Naldan, M. E., Yılmaz, A., Koçak, M. N., & Beydemir, Ş. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17953 · Cited by 5 · see citing works

Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases—2nd Edition

Cervellati, C., & Marsillach, J. (2025) · Antioxidants · doi:10.3390/antiox14030358 · Cited by 4 · see citing works

PON1 and PON3 in Alzheimer’s Disease: Similar Functions but Different Roles

Trentini, A., Rosta, V., Riccetti, R., Mola, G., Galletti, R., Pinotti, M., Senia, V., Zuliani, G., & Cervellati, C. (2024) · Antioxidants · doi:10.3390/antiox13101216 · Cited by 5 · see citing works

Association between lipoprotein-associated phospholipase A2 and 25-hydroxy-vitamin D on early stage diabetic kidney disease in patients with type-2 diabetes mellitus

Zhang, Z., Xiang, Q., Sun, Z., Chen, C., & Gu, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35635 · Cited by 4 · see citing works

The genetics of phospholipase A2 induced redox signaling in neuroinflammation and neuronal diseases

Maiti, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95698-7.00017-6 · Cited by 2 · see citing works

Unveiling the Neuroprotective Effect of Paraoxonase 1 in Neurodegenerative Diseases Focusing on Alzheimer’s Disease

Ismail, A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Faheem, S. A., & Batiha, G. E. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05493-1 · Cited by 2 · see citing works

Systemic Inflammation and Oxidative Stress Markers in Patients With Medication Overuse Headache

Li, C., He, P., Li, Y., Ma, M., Chen, N., Liu, Q., Zhang, Y., Jiang, X., Li, S., Lang, H., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.71004 · Cited by 2 · see citing works

Cuban Policosanol (Raydel®) Exhibited Potent Anti-inflammatory Activity in the Liver and Protection of the Ovary and Testis with an Improvement of Blood Lipid Profile by 12 Weeks Supplementation in Hyperlipidemic Zebrafish: Comparison Study of Efficacy with Three Chinese PolicosanolsPreprint

Cho, K., Kim, J. E., & Baek, S. H. (2023) · Preprints.org · doi:10.20944/preprints202307.1004.v1 · Cited by 2 · see citing works

HDL Cholesterol Levels and Pancreatic Cancer Risk: Protective Effects Revealed

Shao, Y., Hao, R., Lin, S., Ma, B.-F., Ye, J., Maimaiti, M., & Maimaitiyiming, Y. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096334509241218141459 · Cited by 1 · see citing works

A comprehensive study of Alzheimer’s disease biomarkers in plasma and cerebrospinal fluid

Minochkin, A. K., Lobzin, V. Y., Emelin, А. Y., Kopteva, Y. P., Клиценко, О. А., Апалько, С. В., & Shcherbak, S. G. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512504243 · Cited by 1 · see citing works

A-esterase

Adeli, I., MohammadSadeghi, H., & Bameri, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.01058-7

Biomarkers of neuroinflammation and microcirculatory dysfunction in Alzheimer's disease: a comprehensive assessment of the pathogenetic and diagnostic role

Константинович, М. А., Lobzin, V. Y., Николаевна, С. Н., Попов, О. С., Апалько, С. В., Kopteva, Y. P., Ponomareva, S., & Shcherbak, S. G. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-2-29-38

High-density lipoprotein cholesterol protects against delayed encephalopathy after acute carbon monoxide poisoning

Mu, Y., Gao, N., Wang, Y., Wang, S., & Pang, L. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117663

The association between high-density lipoprotein cholesterol and depressive symptoms: The moderating role of inflammation

Wang, Z., Jiang, H., Xu, L., Sun, P., Zhao, Y., Zong, L., & Wang, Z. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121286

High-density lipoprotein cholesterol and cognitive function in patients undergoing hemodialysis

Kato, K., Nakashima, A., Aizawa, C., Kobayashi, A., Shinagawa, S., Ohkido, I., Urashima, M., & Yokoo, T. (2026) · Clinical and Experimental Nephrology · doi:10.1007/s10157-026-02879-w

Life’s crucial 9, plasma proteomics, and the risk of major complications and mortality in MASLD

Zhang, B., Wang, Y.-X., Huang, H.-X., Tang, X.-L., Lai, S., Xiong, Z., Kuang, L., Chen, H., Zhu, H., Li, Y., et al. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00124-2

Prognostic value of the atherogenic index of plasma combined with lactate-to-albumin ratio for in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Jin, Y., Yang, K., & Yao, L. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1816471

Neurotrophic regulation of lipid metabolism in Alzheimer's disease: Mechanisms and therapeutic implications

Fan, D., Zhai, W., Zhang, Q., Li, J., Wang, Y., & Sun, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261499707

Efficacy and Safety of Cuban Policosanol on Cognitive Function and Antioxidant Status in Adults with Subjective Memory Decline: A 12-Week Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial

Cho, K., Lee, Y., Kang, M. J., & Yadav, D. (2026) · Nutrients · doi:10.3390/nu18213496

HDL Proteome and Alzheimer’s Disease: Evidence of a Link

Marsillach, J., Adorni, M. P., Zimetti, F., Papotti, B., Zuliani, G., & Cervellati, C. (2020) · Antioxidants · doi:10.3390/antiox9121224 · Cited by 57 · see citing works

Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease

Bergt, C., Nakano, T., Ditterich, J., DeCarli, C. S., & Eiserich, J. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.019 · Cited by 13 · see citing works

Myeloperoxidase and inflammatory proteins: Pathways for generating dysfunctional high-density lipoprotein in humans

Vaisar, T., Shao, B., Green, P. S., Oda, M. N., Oram, J. F., & Heinecke, J. W. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0054-z · Cited by 24 · see citing works

High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease

Pedrini, S., Chatterjee, P., Hone, E., & Martins, R. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15170 · Cited by 22 · see citing works

HDL ‐Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS

Huang, Y., Tang, J., Chen, G., Wu, Q., Wang, Y., Chen, J., Chen, S., Liu, J., & Huang, X. (2025) · Aging Medicine · doi:10.1002/agm2.70008 · Cited by 3 · see citing works